Raw Materials & Excipients Management – Page 12

Supplier grade substitution during supplier qualification – risk assessment for excipient choice

Identifying the initial signals of potential issues stemming from supplier grade substitution is crucial for a timely response. Symptoms may manifest in various forms, including:Click to read the full article.

Functional performance failure during regulatory review – regulatory scrutiny of excipient data

Identifying early symptoms of functional performance failures is crucial in managing raw material integrity and ensuring compliance during regulatory reviews. Symptoms can manifest in various forms, affecting different stages of…

Functional performance failure during scale-up – risk assessment for excipient choice

Detecting symptoms of functional performance failures is crucial in maintaining quality standards. Common signals may include:Click to read the full article.

Functional performance failure during formulation development – risk assessment for excipient choice

Recognizing symptoms signaling functional performance failures early in the formulation development process is vital. Such symptoms may manifest as:Click to read the full article.

Moisture sensitivity overlooked during formulation development – CAPA for formulation failures

Identifying symptoms related to moisture sensitivity is crucial for prompt action. Common indicators that may signal a moisture issue in formulations include:Click to read the full article.

Excipient incompatibility with API during supplier qualification – preventing late-stage reformulation

Identifying symptoms of excipient incompatibility with APIs is crucial in the early stages of manufacturing. Common signals include:Click to read the full article.

Moisture sensitivity overlooked during stability assessment – compatibility study expectations

Detecting moisture sensitivity issues early involves closely monitoring manufacturing processes and laboratory results. Symptoms may manifest as:Click to read the full article.

Functional performance failure during formulation development – compatibility study expectations

Symptoms of functional performance failure can vary based on the formulation and materials involved. Here are common signals that may prompt a deeper investigation:Click to read the full article.

Excipient incompatibility with API during scale-up – preventing late-stage reformulation

Identifying symptoms is the first step in addressing excipient incompatibility with APIs. The following signals may indicate potential incompatibility issues during scale-up:Click to read the full article.

Unjustified excipient choice during regulatory review – CAPA for formulation failures

Recognizing the early signs of formulation failures related to unjustified excipient choices is crucial. Common indications include:Click to read the full article.

Functional performance failure during formulation development – preventing late-stage reformulation

Identifying signs of functional performance failures is the first step in any successful investigation. Symptoms may manifest in various forms during different stages of formulation development, such as:Click to read…

Moisture sensitivity overlooked during formulation development – regulatory scrutiny of excipient data

Symptoms indicative of moisture sensitivity issues may vary from obvious disruptions in the manufacturing process to subtler signals indicating potential problems with excipients and active pharmaceutical ingredients (APIs). These symptoms…